To this end, we first studied by immunohistochemical staining ADO expression levels in a tissue microarray containing 108 glioma patient samples ranging from grade 2 to grade 4, and 18 normal control brain sections obtained from intracranial aneurysms and peritumor. Here, ADO is linked to central nervous system cancer.